Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioidsKeith M. Olson, John M. Streicher, David I. Duron et al.|PLoS ONE|2019Cited by 54
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain.Keith M. Olson, John M. Streicher, Wei Lei et al.|PubMed|2017Cited by 45
Synthesis and Evaluation of a Novel Bivalent Selective Antagonist for the Mu-Delta Opioid Receptor Heterodimer that Reduces Morphine Withdrawal in MiceKeith M. Olson, John M. Streicher, Attila Keresztes et al.|Journal of Medicinal Chemistry|2018Cited by 44